Home Your basket
• Recurrences of pleomorphi...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• Laryngeal tuberculosis: a...
   Price 8.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• Mucoepidermoid carcinomas...
   Price 10.50 €
• MIF in Head and Neck canc...
   Price 10.50 €
• Transsexuality: Speech th...
   Price 10.50 €
• Adaptation and validation...
   Price 10.50 €
• The Bell Labs contributio...
   Price 12.50 €
• Toxic nodular goitre asso...
   Price 5.50 €
• Progressive cochleo-vesti...
   Price 5.50 €
• Postural study on healthy...
   Price 10.50 €
• Multidisciplinary daytime...
   Price 12.00 €
• Reconstruction of the ant...
   Price 8.50 €
• Temporal lift...
   Price 10.50 €
• Is ethmoidal adenocarcino...
   Price 10.50 €
• Social consequence of a d...
   Price 10.50 €
• Failure rate and revision...
   Price 10.50 €
• Treatment of acute mastoi...
   Price 8.50 €
• Zenker’s diverticulum in ...
   Price 8.50 €
• Positioning in the oropha...
   Price 8.50 €
• Anosmia following superio...
   Price 5.50 €
• Epitympanic osteoma of th...
   Price 12.50 €
• A simple assessment of qu...
   Price 10.50 €
• Bell's palsy: treatment b...
   Price 5.50 €
• Partial allotransplantati...
   Price 10.50 €
• Temporary loss of visual ...
   Price 8.50 €
• Aesthetic augmentation of...
   Price 10.50 €
• Fungal sinusitis: Report ...
   Price 10.50 €
• Cutaneous horn of the pin...
   Price 5.50 €
• Functional septal surgery...
   Price 10.50 €
• Audit of headache followi...
   Price 5.50 €
• Recurrent ameloblastoma o...
   Price 8.50 €
• Surgery of the semicircul...
   Price 12.50 €
• Ossiculoplasty with hydro...
   Price 10.50 €
• Facial paralysis: Functio...
   Price 10.50 €
• The complications of end...
   Price 8.50 €
• Lifting of the oval face ...
   Price 10.50 €
• Going from the tube feedi...
   Price 8.50 €
• Side-to-end hypoglossal-f...
   Price 10.50 €
• Otomycosis due to Scopula...
   Price 10.50 €
• Endobronchial lipomas and...
   Price 5.50 €
• Viral assumption and inve...
   Price 10.50 €
• Feasibility study of sept...
   Price 10.50 €
• Rhinophyma in a black afr...
   Price 5.50 €
• Functional comparison of ...
   Price 14.00 €
• Perceptual assessment of ...
   Price 10.50 €
• Medical rhinoplasty: Rati...
   Price 10.00 €
• Middle ear barotraumas du...
   Price 8.50 €
• Vision preference in dyna...
   Price 10.50 €
• Voice-breaking in adolesc...
   Price 10.50 €
• Usher type I syndrome in ...
   Price 10.50 €
• A schwannoma of the hypog...
   Price 8.50 €
• Papillary thyroid microca...
   Price 10.50 €
• Otolaryngological aspects...
   Price 8.50 €
• Rare benin tumors of the ...
   Price 5.50 €
• A clinico-radiological st...
   Price 10.50 €
• Bronchogenic cyst of the ...
   Price 10.50 €
• Interest of the chest CT ...
   Price 10.50 €
• Otoplasty for prominent e...
   Price 8.50 €
• The outcome of treatments...
   Price 10.50 €
• Cervical and pharyngeal i...
   Price 5.50 €
• Evaluation of the use of ...
   Price 8.50 €
• DROP ATTACKS revealed a ...
   Price 10.00 €
• Lipoma of the larynx: Fib...
   Price 8.00 €
• Prosody and reading: Temp...
   Price 12.00 €
• The frontal pneumosinus d...
   Price 8.50 €
• Can homograft ossicles st...
   Price 5.50 €
• Transoral surgical treatm...
   Price 8.50 €
• Quality of life after rad...
   Price 10.50 €
• Chronitis tonsillitis...
   Price 8.50 €
• A specific plain X-ray in...
   Price 8.50 €
• Failure to regain full fu...
   Price 10.50 €
• Pharyngeal pouch surgery ...
   Price 5.50 €
• Botulinum toxin in the lo...
   Price 14.00 €
• Pulsatile tinnitus and ve...
   Price 8.50 €
• Rhinoplasty: Advantages a...
   Price 10.50 €
• Induction chemotherapy an...
   Price 10.50 €

Total Order 723.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Download
o Issue N# 1 - 1999 o

CERVICO-FACIAL CARCINOLOGY

Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence ?


Authors : G. Dolivet, P. Colosetti, J. L. Merlin, Cl. Depardieu, M. Lapeyre, E. Wattel, J. Sarini, J. Ton Van, L. Geoffrois, Ph. Lagarde (Vandoeuvre les Nancy)

Ref. : Rev Laryngol Otol Rhinol 1999;120,1:5-12.

Article published in french



Summary : The study of epidemiology and of the carcinogenesis in epidermoid carcinomas of the upper aerodigestive tract shows that their occurrence is not random. Tobacco abuse plays a major role, especially because of benzopyrene, mutagen of the P53 gene, however it is associated with many other potentiating factors : alcohol, metals, hydrocarbures, virus, food, climate, genetic fragility that create genetic lesions at the origin of carcinogenesis. The latter occurs as "field cancerization" with multiple alterations of the mucosa and general attack of the control systems of the differentiation, growth and cell apoptosis which usually protect the cell against the phenomena of carcinogenesis. The P53 protein gene, retinoid receptors as well as the system of detoxifying glutathion S transferase are modified at the very early stage of these diseases, these abnormalities can be logically related to epidemiological data. These date lead us therefore to imagine complementary specific reverting therapies of induced genetic abnormalities, through the reexpression of non mutated gene encoding P53 protein and the use of retinoid. These various modalities are reported hereafter.


|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE